Delineation of the border zone of ischemic rabbit myocardium by a technetium-labeled nitroimidazole

Nuclear Medicine and Biology

Volumn 24, Issue 3, 1997, Pages 201-207

  Di Rocco, Richard J ^a,b   Bauer, Al A ^a   Pirro, John P ^a   Kuczynski, Bruce L ^a   Belnavis, Lilian ^a   Chan, Yee Wai ^a   Linder, Karen E ^a   Narra, Rama K ^a   Nowotnik, David P ^a   Nunn, Adrian D ^a  

^a BRISTOL MYERS SQUIBB   (United States)

^b CEPHALON INC   (United States)

Author keywords

Artery; Glycolysis; Hypoxia; Misonidazole; Myocardial ischemia; Myocardial viability; Nuclear cardiology; Relative myocardial blood flow (rMBF)

Indexed keywords

DEOXYGLUCOSE; MISONIDAZOLE; OXO[3,3,9,9 TETRAMETHYL 1 (2 NITRO 1H IMIDAZOL 1 YL) 4,8 DIAZAUNDECANE 2,10 DIONEDIOXIMATO]TECHNETIUM TC 99M; TEBOROXIME TC 99M;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AUTORADIOGRAPHY; COMPUTER ANALYSIS; DRUG DISTRIBUTION; DRUG UPTAKE; HEART INFARCTION; HEART MUSCLE BLOOD FLOW; HEART MUSCLE ISCHEMIA; IMAGE ANALYSIS; LEFT ANTERIOR DESCENDING CORONARY ARTERY; LIPOPHILICITY; MALE; NONHUMAN;

EID: 0030785708     PISSN: 09698051     EISSN: None     Source Type: Journal    
DOI: 10.1016/0969-8051(95)02035-7     Document Type: Article

References (29)

1. 15O. Circulation. 70, 724-733.
2. Di Rocco R. J., Kuczynski B. L., Pirro J. P., Bauer A. A., Linder K. E., Ramalingam K., Cyr J. E., Chan Y. W., Raju N., Narra R. K., Nowotnik D. P. and Nunn A. D. (1993) Imaging ischemic tissue at risk of infarction during stroke. J. CBF Metab. 13, 755-762.
3. Di Rocco R. J., Rumsey W. L., Kuczynski B. S., Linder K. E., Pirro J. P., Narra R. K. and Nunn A. D. (1992) Measurement of myocardial blood flow using a co-injection technique for technetium-99m-teboroxime, technetium-96-SestaMIBI and thallium-201. J. Nucl. Med. 33, 1152-1159.
4. Gallistel C. R., Piner C. T., Allen T. O., Adler N. T., Yadin E. and Negin M. (1982) Computer assisted analysis of 2-DG autoradiographs. Neurosc. Biobehav. Rev. 6, 409-420.
5. Goldstein R. A., Mullani N. A., Wong W. H., Hartz R. K., Hicks C. H., Fuentes F., Smalling R. W. and Gould K. L. (1986) Positron imaging of myocardial infarction with Rubidium-82. J. Nucl. Med. 27, 1824-1829.
6. Gould K. L., Yoshida K., Hess M. J., Haynie M., Mullani N. and Smalling R. W. (1991) Myocardial metabolism of fluorodeoxyglucose compared to cell membrane integrity for the potassium analogue Rubidium-82 for assessing infarct size in man by PET. J. Nucl. Med. 32, 1-9.
7. Gropler R. J. and Bergman S. R. (1991) Myocardial viability - What is the definition? J. Nucl. Med. 32, 10-12.
8. Janse M. J., Cinca J., Morena H., Fiolet J. W. T., Kleber A. G., De Vries G. P., Becker A. E. and Durrer D. (1979) The "border zone" in myocardial ischemia. An electrophysiological, metabolic, and histochemical correlation in the pig heart. Circ. Res. 44, 576-588.
9. Koch C. J., Stobbe C. C. and Baer K. A. (1984) Metabolism induced binding of C-14 misonidazole to hypoxic cells: Kinetic dependence on oxygen concentration and misonidazole concentration. Int. J. Radiat. Oncol. Biol. Phys. 10, 1327-1332.
10. Liedtke A. J., Nellis S. H. and Whitesell L. F. (1982) Effects of regional ischemia on metabolic function in adjacent aerobic myocardium. J. Mol. Cell Cardiol. 14, 195-205.
11. Linder K. E., Chan Y. W., Cyr J. E., Malley M. F., Nowotnik D. P. and Nunn A. D. (1994) Tc(PnAO-1-(2-nitroimidazole)) [BMS-181321], a new technetium-containing nitroimidazole complex for imaging hypoxia: Synthesis, characterization and xanthine oxidase catalyzed reduction. J. Med. Chem. 37, 9-17.
12. 2 inhibition of nitroreductase. Biochem. Biophys. Res. Comm. 67, 1267-1274.
13. 18F-labeled fluorodeoxyglucose, and N-13-ammonia. Circulation 67, 766-778.
14. Murdock R. H., Harlan D. M., Morris J. L. III, Pryor W. W. and Cobb F. R. (1983) Transitional blood flow zones between ischemic and nonischemic myocardium in the awake dog. Circ. Res. 52, 451-459.
15. Narra R. K., Nunn A. D., Kucynski B. L., Feld T., Wedeking P. and Eckelman W. C. (1989) A neutral technetium-99m complex for myocardial imaging. J. Nucl. Med. 30, 1830-1837.
16. Neely J. R. and Morgan H. E. (1974) Relationship between carbohydrate and lipid metabolism and the energy balance of heart muscle. Ann. Rev. Physiol. 36, 415-459.
17. Neely J. R., Whitmer J. T. and Rovetto M. J. (1975) Effect of coronary blood flow on glycolytic flux and intracellular pH in isolated rat hearts. Circ. Res. 37, 733-741.
18. Nielson A. P., Morris K. G., Murdock R., Bruno F. P. and Cobb F. R. (1980) Linear relationship between the distribution of thallium-201 and blood flow in ischemic and nonischemic myocardium during exercise. Circulation 61, 797-801.
19. Roizen-Towle L., Hall E. J. and Pirro J. P. (1986) Oxygen dependence for chemosensitization by misonidazole. Br. J. Cancer 54, 919-924.
20. Rumsey W. L., Cyr J. E., Raju N. and Narra R. K. (1993) A novel[99m]technetium-labeled nitroheterocyde capable of identification of hypoxia in the heart. Biochm. Biophys. Res. Comm. 193(3), 1239-1246.
21. Schelbert H. R., Weisenberg G., Phelps M. E., Gould K. L., Eberhard H., Hoffman E. J., Gormesm A. and Kuhl D. E. (1982) Noninvasive assessment of coronary stenosis by myocardial imaging during pharmacological vasodilation. VI. Detection of coronary artery disease in man with intravenous N-13 ammonia and positron computed tomography. Am. J. Cardiol. 49, 1197-1207.
22. Seldm D. W., Johnson L. L., Blood D. K., Muschel M. J., Smith K. F., Wall R. M. and Cannon P. J. (1989) Myocardial perfusion imaging with technetium-99m SQ 30217: Comparison with thallium-201 and coronary anatomy. J. Nucl. Med. 30, 312-319.
23. Shelton M. E., Dence C. S., Hwang D.-R., Herrero P., Welch M. J. and Bergmann, S. R. (1990) In vivo delineation of myocardial hypoxia during coronary occlusion using fluorine-18 fluoromisonidazole and positron emission tomography: A potential approach for identification of jeopardized myocardium. J. Am. Coll. Cardiol. 16, 477-485.
24. Shelton M. E., Dence C. S., Hwang D.-R. and Welch M. J. (1989) Myocardial kinetics of flourine-18 misonidazole: A marker of hypoxic myocardium. J. Nucl. Med. 30, 351-358.
25. 14C] deoxyglucose method for the measurement of local cerebral glucose utilization: Theory, procedure, and normal values in the conscious and anesthetized albino rat. J. Neurochem. 28, 897-916.
26. Tamaki N., Yonekura Y., Yamashita K., Saji H., Magat Y., Senda M., Konishi Y., Hirata K., Toshihiko B. and Konishi J. (1989) Positron emission tomography using Fluorine-18-deoxyglucose in evaluation of coronary artery bypass grafting. Am. J. Cordiol. 64, 860-865.
27. Tillisch J., Brunker R., Marshall R., Schwaiger M., Mandelkern M., Phelps M. and Schelbert H. (1986) Reversibility of cardiac wall motion abnormalities predicted by positron tomography. N. Engl. J. Med. 314, 884-888.
28. Whackers F. J. Th., Berman, D. S., Maddahi J., Watson D. D., Beller G. A., Strauss H. W., Boucher C. A., Picard M., Holman B. L., Fridrich R., Inglese E., Delaloye B., Bisschof-Delaloye A., Camin L. and McKusick K. (1989) Technetium-99m hexakis 2-methoxyisobutyl isonitrile: Human biodistribution, dosimetry, safety and preliminary comparison to thallium-201 for myocardial perfusion imaging. J. Nucl. Med. 30, 301-311.
29. Williamson J. R., Davis K. N. and Medina-Ramirez G. (1982) Quantitative analysis of heterogenous NADH fluorescence in perfused rat hearts during hypoxia and ischemia. J. Mol. Cell Cardiol. 14(Suppl. 3), 29-35.